ClinicalTrials.gov record
Completed Phase 1 Interventional

A Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

ClinicalTrials.gov ID: NCT05406583

Public ClinicalTrials.gov record NCT05406583. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 11:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase I Study of the Safety, Tolerability, and Pharmacokinetics of Dolutegravir in Neonates Exposed to HIV-1

Study identification

NCT ID
NCT05406583
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
48 participants

Conditions and interventions

Conditions

Interventions

  • Dolutegravir 0.5 mg/kg oral suspension Drug
  • Dolutegravir 5 mg Dispersible Tablets Drug

Drug

Eligibility (public fields only)

Age range
Not listed
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 4, 2022
Primary completion
Mar 11, 2025
Completion
May 21, 2025
Last update posted
Aug 28, 2025

2022 – 2025

United States locations

U.S. sites
8
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
USC - Maternal Child Adolescent/Adult Center Los Angeles California 90033-1075
David Geffen School of Medicine at UCLA NICHD CRS Los Angeles California 90095-1752
University of Colorado Denver NICHD CRS Aurora Colorado 80045
Emory University School of Medicine NICHD CRS Atlanta Georgia 30322
Rush University, Cook County Hospital NICHD CRS Chicago Illinois 60612
Bronx-Lebanon Hospital Center NICHD CRS The Bronx New York 10457
St. Jude Children's Research Hospital Memphis Tennessee 38105-3678
Baylor College of Medicine/ Texas Children's Hospital NICHD CRS Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05406583, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 28, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05406583 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →